This recommendation to the board was regarded by the court as a wish by Boskalis to dismantle the poison pill. Accordingly, it was a strategic matter for the board to decide on. Fugro’s proposal to discuss the anti-takeover measure at its annual meeting was in line with the rationale behind the right of shareholders to put items on the agenda, namely to enhance the dialogue between shareholders and the board. Following the court’s ruling, Boskalis has withdrawn the proposed agenda item.
For the full text of the ruling, please click here (Dutch only).